Product Overview
The DRI Benzodiazepine enzyme immunoassay is a homogeneous assay intended for the qualitative and semi-quantitative determination of benzodiazepines in human urine
Product Features
-
Designed to accurately detect benzodiazepines in various biological samples.
-
Generously sized for multiple tests, reducing the need for frequent restocks.
-
Compatible with a range of automated clinical chemistry analyzers for high-throughput testing.
-
Provides rapid turnaround time for results, enhancing workflow efficiency in clinical settings.
-
Manufactured in compliance with rigorous quality control guidelines to ensure reliability.
Product Specifications
| Catalog Number/SKU | MF-5390012203 |
| Application | Toxicology Reagent |
|---|---|
| For Use With | For Automated Clinical Chemistry Analyzers |
| Form | Ready-to-Use Liquid |
| Sample Type | Urine Sample |
| Specialty | Toxicology |
| Storage Requirements | Requires Refrigeration |
| Test Category | Drugs of Abuse |
| Test Method | Homogeneous Enzyme Immunoassay (HEIA) |
| Test Name | Benzodiazepine (BZO) |
| Test Type | Single Drug |
| UNSPSC Code | 41116007 |
| Volume | 500 mL |
